SpringWorks Therapeutics, Inc.
SpringWorks Therapeutics, Inc. (SWTX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · SWTX · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
29
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
SpringWorks Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
SWTX insider buying and selling by quarter
SWTX insider selling · SWTX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · SWTX ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
SWTX executive sell shares · SWTX board member insider trading · SWTX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 1, 2025 | Edris Badreddin COO | Other | 169,712 | — | Form 4 |
| Jul 1, 2025 | LYNCH DANIEL Director | Other | 93,004 | — | Form 4 |
| Jul 1, 2025 | Lewis-Hall Freda C Director | Other | 24,727 | — | Form 4 |
| Jul 1, 2025 | Hambleton Julie Director | Other | 14,155 | — | Form 4 |
| Jul 1, 2025 | Fuhrman Alan Director | Other | 24,727 | — | Form 4 |
| Jul 1, 2025 | Lin Tai-An Chief Scientific Officer | Other | 33,039 | — | Form 4 |
| Jul 1, 2025 | Ashar Bhavesh Chief Commercial Officer | Other | 62,053 | — | Form 4 |
| Jul 1, 2025 | Cassidy James Chief Medical Officer | Other | 81,731 | — | Form 4 |
| Jul 1, 2025 | MACKAY MARTIN Director | Other | 20,023 | — | Form 4 |
| Jul 1, 2025 | ALBAN CARLOS Director | Other | 28,861 | — | Form 4 |
| Jul 1, 2025 | Nofi Michael CAO | Other | 30,623 | — | Form 4 |
| Jul 1, 2025 | Pichl Daniel CPO | Other | 50,762 | — | Form 4 |
| Jul 1, 2025 | Perier Francis I Jr CFO | Other | 60,889 | — | Form 4 |
| Jul 1, 2025 | Islam Saqib CEO · Director | Other | 954,869 | — | Form 4 |
| Jul 1, 2025 | Weinstein Herschel S General Counsel & Secretary | Other | 55,239 | — | Form 4 |
| May 14, 2025 | LYNCH DANIEL Director | Award | 10,060 | — | Form 4 |
| May 14, 2025 | Lewis-Hall Freda C Director | Award | 10,060 | — | Form 4 |
| May 14, 2025 | Hambleton Julie Director | Award | 10,060 | — | Form 4 |
| May 14, 2025 | Fuhrman Alan Director | Award | 10,060 | — | Form 4 |
| May 14, 2025 | ALBAN CARLOS Director | Award | 10,060 | — | Form 4 |
| May 14, 2025 | MACKAY MARTIN Director | Award | 10,060 | — | Form 4 |
| Mar 3, 2025 | Edris Badreddin COO | Sale | 3,924 | $208K | Form 4 |
| Mar 3, 2025 | Edris Badreddin COO | Sale | 12,078 | $655K | Form 4 |
| Mar 3, 2025 | Edris Badreddin COO | Sale | 3,598 | $198K | Form 4 |
| Mar 3, 2025 | Edris Badreddin COO | Sale | 400 | $22K | Form 4 |
Weinstein Herschel S
General Counsel & Secretary
Date
Jul 1
Shares
55,239
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About SWTX insider trading
SWTX insider trades
SpringWorks Therapeutics, Inc. (SWTX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Edris Badreddin (COO), LYNCH DANIEL (Director), Lewis-Hall Freda C (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. SWTX insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For SpringWorks Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
SWTX insider trading · 5 questionsThe insiders of SpringWorks Therapeutics, Inc. (SWTX) include executives and directors such as Edris Badreddin (COO), LYNCH DANIEL (Director), Lewis-Hall Freda C (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026